FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079706 [Registered on: 29/01/2025] Trial Registered Prospectively
Last Modified On: 17/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Role of The Homoeopathic Medical Repertory By Robin Murphy in Managment of Acute Bronchitis in Pediatric Age Group  
Scientific Title of Study   Role of The Homoeopathic Medical Repertory By Robin Murphy in Managment of Acute Bronchitis in Pediatric Age Group assessed by Bronchitis Severity scale(BSS) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR RASHMINSINH PRATAPSINH THAKOR 
Designation  PG Scholar 
Affiliation  Smt A J Savla Homoeopathic Medical College and Research Institute 
Address  Department of Pediatric Room no 5 ground Floor Smt A J Savla Homoeopathic Medical College and Research Institute Pushpanjali Building Near District Session Court Mehsana

Mahesana
GUJARAT
384001
India 
Phone  9687460885  
Fax    
Email  rashminpthakor@gmail.com  
 
Details of Contact Person
Scientific Query  
Name  DR GAURANG CHHAYA 
Designation  Professor 
Affiliation  Smt A J Savla Homoeopathic Medical College and Research Institute 
Address  Department of Repertory and case taking Room no 14 first Floor Smt A J Savla Homoeopathic Medical College and Research Institute Pushpanjali Building Near District Session Court Mehsana

Mahesana
GUJARAT
384001
India 
Phone  9979885148  
Fax    
Email  chhayagaurang62@gmail.com  
 
Details of Contact Person
Public Query  
Name  DR RASHMINSINH PRATAPSINH THAKOR 
Designation  PG Scholar 
Affiliation  Smt A J Savla Homoeopathic Medical College and Research Institute 
Address  Department of Pediatric Room no 5 ground Floor Smt A J Savla Homoeopathic Medical College and Research Institute Pushpanjali Building Near District Session Court Mehsana

Mahesana
GUJARAT
384001
India 
Phone  9687460885  
Fax    
Email  rashminpthakor@gmail.com  
 
Source of Monetary or Material Support  
Smt A J Savla Homoeopathic Medical College and Research Institute Pushpanjali Building Near District Session Court Building Mehsana Gujarat 384001 
 
Primary Sponsor  
Name  DR RASHMINSINH PRATAPSINH THAKOR 
Address  Department of Pediatric Room no 5 ground Floor Smt A J Savla Homoeopathic Medical College and Research Institute Pushpanjali Building Near District Session Court Mehsana 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR RASHMINSINH PRATAPSINH THAKOR  Smt A J Savla Homoeopathic Medical College and Research Institute  Department of Pediatric Room no 5 ground Floor Smt A J Savla Homoeopathic Medical College and Research Institute Pushpanjali Building Near District Session Court Mehsana
Mahesana
GUJARAT 		 09687460885

rashminpthakor@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Smt A J Savla Homoeopathic Medical College Institutional Ethical Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J209||Acute bronchitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathic Medicines  Potency various such as Centicimal Decimal 50 Millesimal etc Doses As per need of cases Medicines Will be Dispended as per potency Frequency as per the need of cases Route of administration oral Duration of therapy upto for 2 months as per need of case 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  18.00 Year(s)
Gender  Both 
Details  Cases with clinically presented Symptoms of acute bronchitis which include Cough wheezing chest pain or discomfort mild fever and dyspnoea which are last for 7 to 14 days but the symptoms of cough may last for 3 to 4 weeks
Cases in which parents are giving consent 
 
ExclusionCriteria 
Details  Patients or their parents who are unable to provide their medical history in their own words such as individuals with communication difficulties or cognitive impairments including those who are unable to express themselves effectively
Patients with other diagnosed chronic respiratory comorbidity like chronic bronchitis Asthma Tuberculosis ILD etc and DM 1 Genetic anomalies CHD chronic liver disease etc
Patients with pathologies like Malignancy
Spo2 below 90 percentage on room air
Urine output below 1 ml per kg per hour
Patients having or using other medications such as homoeopathy Allopathy etc for the same disease 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Acute Bronchitis will assessed with Bronchitis severity scale  At baseline of study and at the end of treatment 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "80"
Final Enrollment numbers achieved (India)="80" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   10/02/2025 
Date of Study Completion (India) 01/01/2026 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 01/01/2026 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  		 Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is prospective pre test post test one group experimental study to see the changes in the bronchitis severity scale using medicine chosen through Murthy’s repertory in acute bronchitis in pediatric age group within 2 months of study duration in 80 participants as per inclusion and exclusion criteria from outpatient department and to scrutinizing various rubrics for acute bronchitis from  Murphy’s repertory which are helpful in pediatric cases.

 
Close